Cargando…
Drug design : cutting edge approaches /
Pharmaceutical research draws on increasingly complex techniques to solve the challenges of drug design. Bringing together a number of the latest informatics techniques, this book looks at modelling and bioinformatic strategies; structural genomics and X-ray crystallography; virtual screening; lead...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge, UK :
Royal Society of Chemistry,
©2002.
|
| Colección: | Special publication (Royal Society of Chemistry (Great Britain)) ;
no. 279. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | KNOVEL_ocm71842195 | ||
| 003 | OCoLC | ||
| 005 | 20231027140348.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 061005s2002 enka ob 101 0 eng d | ||
| 010 | |z 2006270060 | ||
| 040 | |a KNOVL |b eng |e pn |c KNOVL |d TEF |d BAKER |d OCLCQ |d CUS |d OCLCQ |d AU@ |d OKU |d ZOZ |d UKRSC |d U5D |d N$T |d OCLCO |d E7B |d KNOVL |d ZCU |d KNOVL |d COO |d OCLCE |d OCLCQ |d NLGGC |d OCLCO |d KNOVL |d OCLCQ |d OCLCO |d MHW |d EBLCP |d DHA |d OCLCQ |d OCLCF |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d YDXCP |d AZK |d LOA |d OCLCO |d OCLCA |d COCUF |d UAB |d MOR |d CCO |d OCLCO |d PIFAG |d OCLCO |d MERUC |d OCLCO |d OCLCQ |d IGB |d OCLCO |d OCLCA |d U3W |d NJR |d BUF |d MERER |d CUY |d D6H |d CN8ML |d OCL |d OCLCQ |d INARC |d STF |d VNS |d WRM |d OCLCO |d VTS |d RRP |d OCLCQ |d ICG |d NLE |d NRAMU |d VT2 |d OCLCQ |d UKMGB |d WYU |d OCLCO |d OCLCQ |d S9I |d OCLCO |d OCLCA |d LEAUB |d OCLCQ |d DKC |d OCLCQ |d M8D |d OCLCO |d LIP |d UKAHL |d U3G |d CEF |d UX1 |d OL$ |d OCLCO |d OCLCQ |d AUD |d IEUOL |d HS0 |d UWK |d ERF |d ADU |d UKBTH |d NLW |d OCLCQ |d OCLCA |d OCLCQ |d ZHM |d OCLCA |d UKCRE |d MM9 |d OCLCQ |d OCLCO |d OCLCQ |d DGN |d OCLCO |d OCLCQ |d OCL | ||
| 015 | |a GBA277599 |2 bnb | ||
| 015 | |a GBB6G5266 |2 bnb | ||
| 016 | 7 | |a 101174818 |2 DNLM | |
| 016 | 7 | |a 018021058 |2 Uk | |
| 019 | |a 223451489 |a 227344036 |a 232637347 |a 643999007 |a 692544141 |a 843641090 |a 956412965 |a 961676667 |a 962603551 |a 965973944 |a 974761253 |a 974861637 |a 988510382 |a 991927432 |a 1011791137 |a 1018008840 |a 1027301074 |a 1033597340 |a 1037795165 |a 1038621107 |a 1043609968 |a 1045533012 |a 1058680462 |a 1062277799 |a 1065672995 |a 1086496665 |a 1086548919 |a 1086959117 |a 1100830016 |a 1101728632 |a 1102536871 |a 1105590595 |a 1107151044 |a 1109315105 |a 1110319404 |a 1110807487 |a 1113253634 |a 1113602781 |a 1119034541 |a 1119428704 |a 1119976237 |a 1120919989 |a 1153542051 |a 1157039021 |a 1159638435 |a 1228528273 | ||
| 020 | |a 0854048162 |q (electronic bk.) | ||
| 020 | |a 9780854048168 |q (electronic bk.) | ||
| 020 | |a 9781847550705 |q (electronic bk.) | ||
| 020 | |a 1847550703 |q (electronic bk.) | ||
| 020 | |a 1601190271 | ||
| 020 | |a 9781601190277 | ||
| 029 | 1 | |a AU@ |b 000024210288 | |
| 029 | 1 | |a AU@ |b 000043460914 | |
| 029 | 1 | |a AU@ |b 000051476624 | |
| 029 | 1 | |a AU@ |b 000058156379 | |
| 029 | 1 | |a DEBBG |b BV044175065 | |
| 029 | 1 | |a GBVCP |b 802175384 | |
| 029 | 1 | |a NZ1 |b 11092201 | |
| 029 | 1 | |a NZ1 |b 12767787 | |
| 029 | 1 | |a NZ1 |b 12769212 | |
| 029 | 1 | |a NZ1 |b 15623265 | |
| 029 | 1 | |a UKMGB |b 018021058 | |
| 035 | |a (OCoLC)71842195 |z (OCoLC)223451489 |z (OCoLC)227344036 |z (OCoLC)232637347 |z (OCoLC)643999007 |z (OCoLC)692544141 |z (OCoLC)843641090 |z (OCoLC)956412965 |z (OCoLC)961676667 |z (OCoLC)962603551 |z (OCoLC)965973944 |z (OCoLC)974761253 |z (OCoLC)974861637 |z (OCoLC)988510382 |z (OCoLC)991927432 |z (OCoLC)1011791137 |z (OCoLC)1018008840 |z (OCoLC)1027301074 |z (OCoLC)1033597340 |z (OCoLC)1037795165 |z (OCoLC)1038621107 |z (OCoLC)1043609968 |z (OCoLC)1045533012 |z (OCoLC)1058680462 |z (OCoLC)1062277799 |z (OCoLC)1065672995 |z (OCoLC)1086496665 |z (OCoLC)1086548919 |z (OCoLC)1086959117 |z (OCoLC)1100830016 |z (OCoLC)1101728632 |z (OCoLC)1102536871 |z (OCoLC)1105590595 |z (OCoLC)1107151044 |z (OCoLC)1109315105 |z (OCoLC)1110319404 |z (OCoLC)1110807487 |z (OCoLC)1113253634 |z (OCoLC)1113602781 |z (OCoLC)1119034541 |z (OCoLC)1119428704 |z (OCoLC)1119976237 |z (OCoLC)1120919989 |z (OCoLC)1153542051 |z (OCoLC)1157039021 |z (OCoLC)1159638435 |z (OCoLC)1228528273 | ||
| 037 | |b Knovel Corporation |n http://www.knovel.com | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RS420 |b .D7825 2002eb | |
| 060 | 4 | |a 2003 G-808 | |
| 060 | 4 | |a QV 744 |b D7931 2002 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 072 | 7 | |a PN |2 bicssc | |
| 072 | 7 | |a SCI |2 eflch | |
| 082 | 0 | 4 | |a 615.19 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Drug design : |b cutting edge approaches / |c edited by Darren R. Flower. |
| 260 | |a Cambridge, UK : |b Royal Society of Chemistry, |c ©2002. | ||
| 300 | |a 1 online resource (x, 192 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 490 | 1 | |a Special publication ; |v no. 279 | |
| 500 | |a "The proceedings of the meeting on Cutting Edge Approaches to Drug Design held on 13 March 2001 at the Scientific Societies Lecture Theatre, London, UK"--Title page verso | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Molecular informatics : sharpening drug design's cutting edge -- High-throughput X-ray crystallography for drug discovery -- Trawling the genome for G protein-coupled receptors : the importance of integrating bioinformatic approaches -- Virtual screening of virtual libraries : an efficient startegy for lead generation -- Virtual techniques for lead optimisation -- The impact of physical organic chemistry on the control of drug-like properties -- Mutagenesis and modelling highlight the critical nature of the TM2-loop-TM3 region of biogenic amine GPCRs -- Computational vaccine design. | |
| 520 | |a Pharmaceutical research draws on increasingly complex techniques to solve the challenges of drug design. Bringing together a number of the latest informatics techniques, this book looks at modelling and bioinformatic strategies; structural genomics and X-ray crystallography; virtual screening; lead optimisation; ADME profiling and vaccine design. A number of relevant case studies, focussing on techniques that have demonstrated their use, will concentrate on G-protein coupled receptors as potential disease targets. Providing details of state-of-the-art research, Drug Design: Cutting Edge Approaches will be invaluable to all drug discovery scientists, including medicinal and combinatorial chemists, molecular modellers, bio- and chemoinformaticians, and pharmacologists, amongst others. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 546 | |a English. | ||
| 506 | 1 | |a Legal Deposit; |c Only available on premises controlled by the deposit library and to one user at any one time; |e The Legal Deposit Libraries (Non-Print Works) Regulations (UK). |5 WlAbNL | |
| 540 | |a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force. |5 WlAbNL | ||
| 590 | |a Knovel |b ACADEMIC - Pharmaceuticals, Cosmetics & Toiletries | ||
| 650 | 0 | |a Drugs |x Design |v Congresses. | |
| 650 | 0 | |a Drugs |x Design |x Mathematical models |v Congresses. | |
| 650 | 0 | |a Artificial intelligence |x Medical applications |v Congresses. | |
| 650 | 0 | |a Drugs |x Research |x Methodology |v Congresses. | |
| 650 | 0 | |a Mathematical models. | |
| 650 | 0 | |a Pharmaceutical technology. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Chemistry. | |
| 650 | 0 | |a Physical sciences. | |
| 650 | 0 | |a Life sciences. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 0 | |a Methodology. | |
| 650 | 0 | |a Chemical models. | |
| 650 | 0 | |a Molecular pharmacology |x Computer simulation. | |
| 650 | 0 | |a Pharmacology, Experimental |x Computer simulation. | |
| 650 | 0 | |a Computer simulation. | |
| 650 | 0 | |a Digital computer simulation. | |
| 650 | 2 | |a Drug Discovery | |
| 650 | 2 | |a Investigative Techniques | |
| 650 | 2 | |a Publication Formats | |
| 650 | 2 | |a Models, Theoretical | |
| 650 | 2 | |a Computing Methodologies | |
| 650 | 2 | |a Technology, Pharmaceutical | |
| 650 | 2 | |a Publication Characteristics | |
| 650 | 2 | |a Analytical, Diagnostic and Therapeutic Techniques and Equipment | |
| 650 | 2 | |a Chemistry, Pharmaceutical | |
| 650 | 2 | |a Information Science | |
| 650 | 2 | |a Pharmacology | |
| 650 | 2 | |a Chemistry | |
| 650 | 2 | |a Natural Science Disciplines | |
| 650 | 2 | |a Biological Science Disciplines | |
| 650 | 2 | |a Disciplines and Occupations | |
| 650 | 2 | |a Drug Design | |
| 650 | 2 | |a Combinatorial Chemistry Techniques | |
| 650 | 2 | |a Methods | |
| 650 | 2 | |a Congresses | |
| 650 | 2 | |a Models, Chemical | |
| 650 | 2 | |a Computer Simulation | |
| 650 | 6 | |a Médicaments |x Conception. | |
| 650 | 6 | |a Pharmacologie moléculaire |x Simulation par ordinateur. | |
| 650 | 6 | |a Pharmacologie expérimentale |x Simulation par ordinateur. | |
| 650 | 6 | |a Médicaments |x Conception |v Congrès. | |
| 650 | 6 | |a Médicaments |x Conception |x Modèles mathématiques |v Congrès. | |
| 650 | 6 | |a Intelligence artificielle en médecine |v Congrès. | |
| 650 | 6 | |a Médicaments |x Recherche |x Méthodologie |v Congrès. | |
| 650 | 6 | |a Modèles mathématiques. | |
| 650 | 6 | |a Techniques pharmaceutiques. | |
| 650 | 6 | |a Chimie pharmaceutique. | |
| 650 | 6 | |a Pharmacologie. | |
| 650 | 6 | |a Chimie. | |
| 650 | 6 | |a Sciences physiques. | |
| 650 | 6 | |a Sciences de la vie. | |
| 650 | 6 | |a Méthodologie. | |
| 650 | 6 | |a Modèles chimiques. | |
| 650 | 6 | |a Simulation par ordinateur. | |
| 650 | 7 | |a mathematical models. |2 aat | |
| 650 | 7 | |a pharmacology. |2 aat | |
| 650 | 7 | |a chemistry. |2 aat | |
| 650 | 7 | |a physical sciences. |2 aat | |
| 650 | 7 | |a biological sciences. |2 aat | |
| 650 | 7 | |a methodology. |2 aat | |
| 650 | 7 | |a simulation. |2 aat | |
| 650 | 7 | |a Chemistry. |2 bicssc | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a Science. |2 eflch | |
| 650 | 7 | |a Physical sciences. |2 fast |0 (OCoLC)fst01062723 | |
| 650 | 7 | |a Pharmacology. |2 fast |0 (OCoLC)fst01060259 | |
| 650 | 7 | |a Pharmaceutical technology. |2 fast |0 (OCoLC)fst01060211 | |
| 650 | 7 | |a Pharmaceutical chemistry. |2 fast |0 (OCoLC)fst01060115 | |
| 650 | 7 | |a Methodology. |2 fast |0 (OCoLC)fst01018722 | |
| 650 | 7 | |a Mathematical models. |2 fast |0 (OCoLC)fst01012085 | |
| 650 | 7 | |a Life sciences. |2 fast |0 (OCoLC)fst00998323 | |
| 650 | 7 | |a Digital computer simulation. |2 fast |0 (OCoLC)fst00893651 | |
| 650 | 7 | |a Computer simulation. |2 fast |0 (OCoLC)fst00872518 | |
| 650 | 7 | |a Chemistry. |2 fast |0 (OCoLC)fst00853344 | |
| 650 | 7 | |a Chemical models. |2 fast |0 (OCoLC)fst00853066 | |
| 650 | 7 | |a Artificial intelligence |x Medical applications. |2 fast |0 (OCoLC)fst00817267 | |
| 650 | 7 | |a Drugs |x Design. |2 fast |0 (OCoLC)fst00898790 | |
| 650 | 7 | |a Drugs |x Research |x Methodology. |2 fast |0 (OCoLC)fst00898904 | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Flower, Darren R. | |
| 776 | 0 | 8 | |i Print version: |t Drug design. |d Cambridge, UK : Royal Society of Chemistry, ©2002 |z 0854048162 |w (DLC) 2006270060 |w (OCoLC)48979833 |
| 830 | 0 | |a Special publication (Royal Society of Chemistry (Great Britain)) ; |v no. 279. | |
| 856 | 4 | 0 | |u https://appknovel.uam.elogim.com/kn/resources/kpDDCEA008/toc |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH30548000 | ||
| 938 | |a Baker & Taylor |b BKTY |c 119.00 |d 119.00 |i 0854048162 |n 0003832932 |s active | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1185420 | ||
| 938 | |a ebrary |b EBRY |n ebr10621270 | ||
| 938 | |a EBSCOhost |b EBSC |n 496156 | ||
| 938 | |a Internet Archive |b INAR |n drugdesigncuttin00flow_0 | ||
| 938 | |a YBP Library Services |b YANK |n 9895039 | ||
| 994 | |a 92 |b IZTAP | ||